Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	139.65	97.25	186.73	125.74	123.67	117.36
Short-Term Investments	434.71	321.66	154.89	111.61	203.24	188.45
Cash & Short-Term Investments	574.36	418.91	341.62	237.36	326.9	305.81
Cash Growth	78.02%	22.63%	43.93%	-27.39%	6.90%	129.90%
Accounts Receivable	22.83	165	10	0.01	1.57	2.43
Other Receivables	4.26	3.49	0.33	0.04	3.77	1.4
Receivables	27.09	168.49	10.33	0.05	5.33	3.82
Prepaid Expenses	4.41	4.24	3.63	5.67	8.5	5.97
Restricted Cash	-	-	-	-	-	0.01
Total Current Assets	605.86	591.64	355.58	243.08	340.74	315.61
Property, Plant & Equipment	12.53	12.61	2.15	4.63	6.73	6.41
Long-Term Investments	123.52	140.25	-	-	-	2
Other Long-Term Assets	0.23	0.23	0.23	0.23	0.23	0.45
Total Assets	742.13	744.73	357.95	247.93	347.7	324.47
Accounts Payable	2.92	1.62	0.77	3.64	1.6	3.08
Accrued Expenses	11.66	23.62	19.26	24.54	37.31	18.42
Current Portion of Leases	1.57	0.51	1.14	2.52	2.2	1.46
Current Income Taxes Payable	1.89	2.69	-	-	-	-
Current Unearned Revenue	16.9	18.89	-	-	1.6	14.48
Other Current Liabilities	0.18	0.07	0.1	0.48	1.31	2.81
Total Current Liabilities	35.11	47.4	21.27	31.18	44.02	40.24
Long-Term Leases	9.79	10.36	-	1.14	3.66	4.5
Long-Term Unearned Revenue	8.18	11.68	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.12
Total Liabilities	53.08	69.43	21.27	32.32	47.67	44.86
Common Stock	0	0	0	-	-	-
Additional Paid-In Capital	1,041	1,016	952.49	752.72	709.68	563.39
Retained Earnings	-352.18	-340.52	-615.71	-536.76	-409.36	-283.81
Comprehensive Income & Other	0.09	-0.08	-0.11	-0.36	-0.3	0.03
Total Common Equity	689.05	675.3	336.68	215.61	300.02	279.61
Shareholders' Equity	689.05	675.3	336.68	215.61	300.02	279.61
Total Liabilities & Equity	742.13	744.73	357.95	247.93	347.7	324.47
Total Debt	11.36	10.87	1.14	3.66	5.86	5.96
Net Cash (Debt)	686.52	548.3	340.48	233.7	321.04	301.85
Net Cash Growth	113.09%	61.04%	45.69%	-27.21%	6.36%	160.20%
Net Cash Per Share	10.57	8.43	6.00	4.77	6.93	8.78
Filing Date Shares Outstanding	61.98	61.38	58.27	51.28	48.41	43.81
Total Common Shares Outstanding	61.93	61.04	57.71	49.34	47.84	43.75
Working Capital	570.75	544.24	334.3	211.9	296.72	275.37
Book Value Per Share	11.13	11.06	5.83	4.37	6.27	6.39
Tangible Book Value	689.05	675.3	336.68	215.61	300.02	279.61
Tangible Book Value Per Share	11.13	11.06	5.83	4.37	6.27	6.39
Machinery	8.03	7.8	6.47	5.91	5.18	4.19
Leasehold Improvements	2.78	2.42	0.96	0.91	0.88	0.75

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q